Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

26.9%

7 terminated/withdrawn out of 26 trials

Success Rate

70.8%

-15.7% vs industry average

Late-Stage Pipeline

2 trials in Phase 3/4

Results Transparency

59%

10 of 17 completed trials have results

Key Signals

10 with results

Enrollment Performance

Analytics

N/A

14(63.6%)

Phase 2

5(22.7%)

Phase 4

1(4.5%)

Phase 1

1(4.5%)

Phase 3

1(4.5%)

22Total

N/A(14)

Phase 2(5)

Phase 4(1)

Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials

NCT02769273Completed

Stellarex Vascular E-Registry

Role: lead

NCT05361967Terminated

Tack Optimized Balloon Angioplasty Post-Market Study

Role: lead

NCT03421561Not ApplicableCompleted

ILLUMENATE Pivotal Post-Approval Study (PAS)

Role: lead

NCT03395236Phase 4Completed

ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study

Role: lead

NCT03175744Not ApplicableSuspended

Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

Role: lead

NCT01927068Not ApplicableCompleted

STELLAREX: ILLUMENATE Global and In-Stent Restenosis (ISR)

Role: lead

NCT01858363Not ApplicableCompleted

ILLUMENATE EU Randomized Clinical Trial

Role: lead

NCT02307370Not ApplicableCompleted

Atherectomy By Laser Ablation With Turbo-Elite

Role: lead

NCT02714153Not ApplicableCompleted

Bridge Occlusion Balloon in Lead Extraction Procedure

Role: collaborator

NCT03284229Not ApplicableCompleted

Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD

Role: lead

NCT01858428Not ApplicableCompleted

Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon

Role: lead

NCT01868984Phase 2Terminated

Paclitaxel for the Treatment of Upper-Extremity Arteriovenous Access Fistula Stenosis

Role: collaborator

NCT02921542Completed

An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies

Role: lead

NCT03268018Not ApplicableCompleted

ModificatiOn and Treatment of stenoseD Calcified inFrainguinal Lesions With Laser atherectomY in a Pilot Study

Role: lead

NCT03306199Completed

TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions

Role: lead

NCT01912937Phase 2Completed

Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries:

Role: lead

NCT01330628Phase 2Completed

Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis

Role: lead

NCT01514994Not ApplicableCompleted

Valvuloplasty Scoring Balloon Catheter First-in-Man Study

Role: lead

NCT02118493Not ApplicableWithdrawn

Endo-biliary Laser Excision of Biliary Stenoses

Role: collaborator

NCT00718991Phase 2Terminated

EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study

Role: collaborator